Kennedy BK, Berger SL, Brunet A, Campisi J, Cuervo AM, Epel ES, et al. Geroscience: linking aging to chronic disease. Cell. 2014;159(4):709–13.
Article CAS PubMed PubMed Central Google Scholar
Singh PP, Demmitt BA, Nath RD, Brunet A. The genetics of aging: a vertebrate perspective. Cell. 2019;177(1):200–20.
Article CAS PubMed PubMed Central Google Scholar
Denzel MS, Lapierre LR, Mack HID. Emerging topics in C. elegans aging research: transcriptional regulation, stress response and epigenetics. Mech Ageing Dev. 2019;177:4–21.
Article CAS PubMed Google Scholar
Longo VD, Antebi A, Bartke A, Barzilai N, Brown-Borg HM, Caruso C, et al. Interventions to slow aging in humans: are we ready? Aging Cell. 2015;14(4):497–510.
Article CAS PubMed PubMed Central Google Scholar
Kenyon C, Chang J, Gensch E, Rudner A, Tabtiang R. A C. elegans mutant that lives twice as long as wild type. Nature. 1993;366(6454):366461a0.
Friedman DB, Johnson TE. A mutation in the age-1 gene in Caenorhabditis elegans lengthens life and reduces hermaphrodite fertility. Genetics. 1988;118(1):75–86.
Article CAS PubMed PubMed Central Google Scholar
Kimura KD, Tissenbaum HA, Liu Y, Ruvkun G. daf-2, an insulin receptor-like gene that regulates longevity and diapause in Caenorhabditis elegans. Science. 1997;277(5328):942–6.
Article CAS PubMed Google Scholar
Kenyon CJ. The genetics of ageing. Nature. 2010;464(7288):504–12.
Article CAS PubMed Google Scholar
Hahm JH, Kim S, DiLoreto R, Shi C, Lee SJV, Murphy CT, et al. C. elegans maximum velocity correlates with healthspan and is maintained in worms with an insulin receptor mutation. Nat Commun. 2015;6(1):8919.
Article CAS PubMed Google Scholar
Statzer C, Reichert P, Dual J, Ewald CY. Longevity interventions temporally scale healthspan in Caenorhabditis elegans. Iscience. 2022;25(3):103983.
Article CAS PubMed PubMed Central Google Scholar
Bansal A, Zhu LJ, Yen K, Tissenbaum HA. Uncoupling lifespan and healthspan in Caenorhabditis elegans longevity mutants. Proc National Acad Sci. 2015;112(3):E277–86.
Ewald CY, Castillo-Quan JI, Blackwell TK. Untangling longevity, dauer, and healthspan in Caenorhabditis elegans insulin/IGF-1-signalling. Gerontology. 2017;64(1):96–104.
Ewald CY, Landis JN, Abate JP, Murphy CT, Blackwell TK. Dauer-independent insulin/IGF-1-signalling implicates collagen remodelling in longevity. Nature. 2015;519(7541):97–101.
Article CAS PubMed Google Scholar
Murphy CT, Hu PJ. Insulin/insulin-like growth factor signaling in C. elegans. WormBook. 2013. p. 1–43. https://doi.org/10.1895/wormbook.1.164.1.
Gems D, Sutton AJ, Sundermeyer ML, Albert PS, King KV, Edgley ML, et al. Two pleiotropic classes of daf-2 mutation affect larval arrest, adult behavior, reproduction and longevity in Caenorhabditis elegans. Genetics. 1998;150(1):129–55.
Article CAS PubMed PubMed Central Google Scholar
Libina N, Berman JR, Kenyon C. Tissue-specific activities of C. elegans DAF-16 in the regulation of lifespan. Cell. 2003;115(4):489–502.
Article CAS PubMed Google Scholar
Riddle DL, Swanson MM, Albert PS. Interacting genes in nematode dauer larva formation. Nature. 1981;290(5808):668–71.
Article CAS PubMed Google Scholar
Garsin DA, Villanueva JM, Begun J, Kim DH, Sifri CD, Calderwood SB, et al. Long-lived C. elegans daf-2 mutants are resistant to bacterial pathogens. Science. 2003;300(5627):1921–1921.
Article CAS PubMed Google Scholar
Lithgow GJ, White TM, Melov S, Johnson TE. Thermotolerance and extended life-span conferred by single-gene mutations and induced by thermal stress. Proc Natl Acad Sci. 1995;92(16):7540–4.
Article CAS PubMed PubMed Central Google Scholar
Murphy CT, McCarroll SA, Bargmann CI, Fraser A, Kamath RS, Ahringer J, et al. Genes that act downstream of DAF-16 to influence the lifespan of Caenorhabditis elegans. Nature. 2003;424(6946):277–83.
Article CAS PubMed Google Scholar
Dillin A, Crawford DK, Kenyon C. Timing requirements for insulin/IGF-1 signaling in C. elegans. Science. 2002;298(5594):830–4.
Article CAS PubMed Google Scholar
Venz R, Pekec T, Katic I, Ciosk R, Ewald CY. End-of-life targeted degradation of DAF-2 insulin/IGF-1 receptor promotes longevity free from growth-related pathologies. Elife. 2021;10:e71335.
Article CAS PubMed PubMed Central Google Scholar
Zhang YP, Zhang WH, Zhang P, Li Q, Sun Y, Wang JW, et al. Intestine-specific removal of DAF-2 nearly doubles lifespan in Caenorhabditis elegans with little fitness cost. Nat Commun. 2022;13(1):6339.
Article CAS PubMed PubMed Central Google Scholar
Roy C, Molin L, Alcolei A, Solyga M, Bonneau B, Vachon C, et al. DAF-2/insulin IGF-1 receptor regulates motility during aging by integrating opposite signaling from muscle and neuronal tissues. Aging Cell. 2022;21(8):e13660.
Article CAS PubMed PubMed Central Google Scholar
Zhang L, Ward JD, Cheng Z, Dernburg AF. The auxin-inducible degradation (AID) system enables versatile conditional protein depletion in C. elegans. Development. 2015;142(24):4374–84.
CAS PubMed PubMed Central Google Scholar
Podshivalova K, Kerr RA, Kenyon C. How a mutation that slows aging can also disproportionately extend end-of-life decrepitude. Cell Rep. 2017;19(3):441–50.
Article CAS PubMed PubMed Central Google Scholar
Garigan D, Hsu AL, Fraser AG, Kamath RS, Ahringer J, Kenyon C. Genetic analysis of tissue aging in Caenorhabditis elegans : a role for heat-shock factor and bacterial proliferation. Genetics. 2002;161(3):1101–12.
Article CAS PubMed PubMed Central Google Scholar
Zhao Y, Gilliat AF, Ziehm M, Turmaine M, Wang H, Ezcurra M, et al. Two forms of death in ageing Caenorhabditis elegans. Nat Commun. 2017;8(1):15458.
Article CAS PubMed PubMed Central Google Scholar
Gems D, Riddle DL. Genetic, behavioral and environmental determinants of male longevity in Caenorhabditis elegans. Genetics. 2000;154(4):1597–610.
Article CAS PubMed PubMed Central Google Scholar
Ezcurra M, Benedetto A, Sornda T, Gilliat AF, Au C, Zhang Q, et al. C. elegans eats its own intestine to make yolk leading to multiple senescent pathologies. Curr Biol. 2018;28(16):2544-2556.e5.
留言 (0)